Feature Image - HPV

HPV

Posted on January 27, 2020 in Vaccines

HPV or Human Papillomavirus Infection is the most common sexually transmitted infection in the United States, according to the CDC. Currently, there is no cure for HPV. Rochester Clinical Research is currently conducting a research study with the FDA approved vaccine Gardasil. This study will help prove that Gardasil not only prevents genital warts and cervical cancer, but also head and neck cancers caused by the same HPV virus.

Read More
Feature Image - Chikungunya: A Mosquito Spread Disease

Chikungunya: A Mosquito Spread Disease

Posted on December 20, 2019 in Vaccines

Did you know mosquitoes can transmit diseases like malaria, dengue, West Nile virus, and chikungunya? Rochester Clinical Research is currently on the forefront of developing one of the first chikungunya vaccines this winter.

Read More
Feature Image - Ebola Vaccine Now Used in Africa

Ebola Vaccine Now Used in Africa

Posted on August 7, 2019 in Vaccines

Rochester Clinical Research conducted an Ebola Vaccine Research study that is currently being used in Africa. It has been 99% effective for those who have gotten the vaccine.

Read More
Feature Image - Smallpox Vaccine Needed for Risk of Bioterrorism

Smallpox Vaccine Needed for Risk of Bioterrorism

Posted on April 29, 2019 in General Vaccines

Routine vaccinations for smallpox ended 40 years ago after the World Health Organization officially declared global eradication of smallpox. This means the majority of the population is not protected. The threat of bioterrorism and natural re-emergence has prompted the US and countries around the world to prepare an updated vaccine which is more effective and easier to store. RCR is currently on the forefront of developing this vaccine.

Read More